Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.
💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.
About Eli Lilly and Company
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provi...
Key info
🎂
Founded
1876
👥
Employees
50 000
💰
Market cap
1 010 343 012 998,00 $US
📊
P/E
40.2
💸
Dividend yield
0.01%
🕴️ Insider activity (90 days)
10 transactions — including 0 buys declared by Eli Lilly and Company executives to SEC / AMF / BaFin.
YI
Yuffa Ilya
EVP&Pres, LLY USA&Global Capab · 2026-06-10
Other
FJ
Fyrwald J Erik
2026-05-18
Other
AR
Alvarez Ralph
2026-05-18
Other
🏦 Hedge Funds
6 institutional funds report a position on LLY in their latest SEC quarterly filing.
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
Russell Investments Group, Ltd.
Baird Financial Group, Inc.
AGF MANAGEMENT LTD
MetLife Investment Management, LLC
📰 Recent news
15 recent articles on LLY.
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know